Fig. 2.

Effect of MC treatment on hepatic FMO3 mRNA in WT and LCN mice. Quantitative analysis of FMO3 mRNA levels, relative to β-actin. Data represent the mean ± S.D. of determinations from four mice per group, expressed as a percentage of the mean for the vehicle-treated WT mice. Outcomes from nonparametric Welch-corrected unpaired t tests (since heterogeneity of variance was detected for FMO3 mRNA) were as follows: *significantly different (P < 0.05) from genotype-matched vehicle-control mice.